Cell BiologybioRxivPreprint
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis
Chittampalli N. Yashaswini, Bruno Cogliati, Tianyue Qin…·Scott L. Friedman
This study evaluates in vivo anti-FAP CAR T therapy for MASH, showing reduced fibrosis and restored liver homeostasis through HSC depletion and immune modulation.
13 citations